PT706401E - Sistema para administracao de farmacos - Google Patents

Sistema para administracao de farmacos

Info

Publication number
PT706401E
PT706401E PT94918945T PT94918945T PT706401E PT 706401 E PT706401 E PT 706401E PT 94918945 T PT94918945 T PT 94918945T PT 94918945 T PT94918945 T PT 94918945T PT 706401 E PT706401 E PT 706401E
Authority
PT
Portugal
Prior art keywords
matrix
drug
receptor
environment
drugs
Prior art date
Application number
PT94918945T
Other languages
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Publication of PT706401E publication Critical patent/PT706401E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT94918945T 1993-06-30 1994-06-27 Sistema para administracao de farmacos PT706401E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939313484A GB9313484D0 (en) 1993-06-30 1993-06-30 Drug system ii

Publications (1)

Publication Number Publication Date
PT706401E true PT706401E (pt) 2003-03-31

Family

ID=10738039

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94918945T PT706401E (pt) 1993-06-30 1994-06-27 Sistema para administracao de farmacos

Country Status (11)

Country Link
US (2) US5902607A (pt)
EP (1) EP0706401B1 (pt)
JP (1) JP4572008B2 (pt)
AT (1) ATE228374T1 (pt)
AU (1) AU7004194A (pt)
DE (1) DE69431800T2 (pt)
DK (1) DK0706401T3 (pt)
ES (1) ES2185654T3 (pt)
GB (1) GB9313484D0 (pt)
PT (1) PT706401E (pt)
WO (1) WO1995001186A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
GB0116860D0 (en) * 2001-07-10 2001-09-05 Univ Montfort Gel compositions
US7531191B2 (en) 2002-12-17 2009-05-12 Massachusetts Institute Of Technology Stimuli-responsive systems for controlled drug delivery
GB0412631D0 (en) * 2004-06-07 2004-07-07 Cambridge Applied Polymers Ltd Polymer release system
EP1877447B1 (en) 2005-05-05 2016-12-21 Sensient Flavors Inc. Production of beta-glucans and mannans
US20070099820A1 (en) * 2005-10-19 2007-05-03 Smartcells, Inc. Polymer-drug conjugates
CA2671900A1 (en) * 2006-12-22 2008-07-03 The Regents Of The University Of California Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
KR20140054404A (ko) 2009-01-28 2014-05-08 스마트쎌스, 인크. 결정질 인슐린-접합체
US8603529B2 (en) * 2009-01-28 2013-12-10 Smartcells, Inc. Polynucleotide aptamer-based cross-linked materials and uses thereof
CA2750223A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
AU2010208305A1 (en) 2009-01-28 2011-09-08 Smartcells, Inc. Synthetic conjugates and uses thereof
PE20120583A1 (es) 2009-01-28 2012-05-19 Smartcells Inc Sistemas basados en conjugados para entrega farmacologica controlada
US8569231B2 (en) 2009-03-20 2013-10-29 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
US9095623B2 (en) * 2009-03-20 2015-08-04 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
US8623345B2 (en) 2009-03-20 2014-01-07 Smartcells Terminally-functionalized conjugates and uses thereof
EP2598527A4 (en) 2010-07-28 2014-01-08 Smartcells Inc RECOMBINANT EXPRESSED INSULIN POLYPEPTIDES AND APPLICATIONS THEREOF
US8933207B2 (en) 2010-07-28 2015-01-13 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
WO2012015691A2 (en) 2010-07-28 2012-02-02 Smartcells, Inc. Recombinant lectins, binding-site modified lectins and uses thereof
CA2902256A1 (en) * 2012-02-17 2013-08-22 Massachusetts Institute Of Technology Self-regulated peptide hydrogel for insulin delivery
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) 2013-08-15 2013-10-02 Univ Montfort Matrix gel
TW201605470A (zh) 2013-10-04 2016-02-16 默沙東藥廠 葡萄糖反應性胰島素結合物
US11041009B2 (en) 2017-03-23 2021-06-22 Merck Sharp & Dohme Corp. Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
US11413352B2 (en) 2017-12-18 2022-08-16 Merck, Sharp & Dohme LLC Conjugate based systems for controlled insulin delivery
WO2019125878A1 (en) 2017-12-18 2019-06-27 Merck Sharp & Dohme Corp. Conjugate based systems for controlled insulin delivery
CN108721605B (zh) * 2018-06-01 2022-10-14 华南师范大学 一种装载有胰岛素的纳米粒子及其应用
IL293852A (en) * 2019-12-13 2022-08-01 Folium Labs Inc Conjugates containing a carbohydrate polymer and an active ingredient and processes for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348387A (en) * 1979-07-31 1982-09-07 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
IE921050A1 (en) * 1991-04-02 1992-10-07 Biotech Australia Pty Ltd Oral delivery systems for microparticles
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system

Also Published As

Publication number Publication date
US5902607A (en) 1999-05-11
JPH09501416A (ja) 1997-02-10
EP0706401A1 (en) 1996-04-17
US6410053B1 (en) 2002-06-25
DE69431800T2 (de) 2003-09-04
WO1995001186A1 (en) 1995-01-12
ES2185654T3 (es) 2003-05-01
EP0706401B1 (en) 2002-11-27
AU7004194A (en) 1995-01-24
JP4572008B2 (ja) 2010-10-27
DK0706401T3 (da) 2003-03-03
GB9313484D0 (en) 1993-08-11
DE69431800D1 (de) 2003-01-09
ATE228374T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
PT706401E (pt) Sistema para administracao de farmacos
US5656284A (en) Oral transmucosal delivery tablet and method of making it
AU660336B2 (en) Device for the transdermal administration of melatonin
DE3853853D1 (de) Verabreichungsformen für Pharmaka.
PT1021171E (pt) Sistema de administracao de farmacos no tracto gastrointestinal de libertacao total prolongada
WO2003077972A8 (en) Implantable drug delivery system
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
AU7465087A (en) Controlled release bioerodible drug delivery system
US20030211157A1 (en) Semi-sol delivery blend for water soluble molecules
BR9805444A (pt) Sistema de implante de pellet
GT199900151A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial.
ATE516049T1 (de) Formulierung zur gesteuerten arzneistofffreisetzung durch kombination hydrophiler und hydrophober stoffe
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
ZA946698B (en) Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
IT1243745B (it) Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
FI960556A0 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
NO993385D0 (no) Transdermalt terapeutisk system for avgivelse av hormoner
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
EP0873751A3 (en) Pharmaceutical product for application to uterus mucosa
EP0325086A3 (en) Novel methods for obtaining therapeutic systems with controlled release of the drug
US20060235038A1 (en) Novel therapeutic uses for nalmefene